Garden G M, Ayres J G
Department of Psychiatry, Kidderminster General Hospital, West Midlands.
Thorax. 1993 May;48(5):501-5. doi: 10.1136/thx.48.5.501.
Many studies have shown that emotional factors play a part in asthma, but few have compared patients with differing severities of asthma. It was our impression that patients with "brittle" asthma (BA; more than 40% diurnal variation in peak flow on 15 or more days a month over a period of at least six months, and persistent symptoms despite multiple drug treatment) had greater psychosocial morbidity than asthmatic patients with less variable asthma.
Twenty patients with BA and a control group of less severe asthmatic subjects matched for age, sex, and duration of illness were asked to complete the General Health Questionnaire (GHQ), a screening test for psychiatric disorders, the Eysenck Personality Inventory which measures extraversion and neuroticism, and to participate in a life events interview and a structured clinical interview (SCID) to diagnose psychiatric disorder.
The mean (SD) age was 45.6 (12.3) years for the BA group, and 45.7 (13.1) years for the control group. All patients were receiving inhaled steroids and regular beta 2 agonists; nine patients with BA but no control patients were taking oral steroids, and 12 of the patients with BA but no controls were receiving beta 2 agonists by subcutaneous infusion or injection. Eight of the patients with BA scored more than 11 on the GHQ compared with five of the control group (NS). Significantly more subjects with BA (12/20) than controls (5/20) had intercurrent or past psychiatric disorder, and 7/20 subjects with BA had a lifetime history of anxiety disorder compared with 3/20 controls. Life events analysis showed no overall difference in the total number, but the patients with BA had significantly more life events related to asthma. There was no difference in personality profiles between the two groups.
The results suggest that patients with "brittle" asthma have greater psychiatric morbidity than those with less severe asthma, but that their personality profiles and overall life event experiences are similar.
许多研究表明,情绪因素在哮喘中起作用,但很少有研究对不同严重程度的哮喘患者进行比较。我们的印象是,“脆性”哮喘(BA;在至少六个月的时间里,每月15天或更多天数的峰值流量日间变化超过40%,且尽管接受多种药物治疗仍有持续症状)患者的心理社会发病率高于哮喘症状变化较小的哮喘患者。
20例BA患者和一组年龄、性别和病程相匹配的病情较轻的哮喘患者作为对照组,被要求完成一般健康问卷(GHQ),这是一种精神疾病筛查测试,艾森克人格问卷用于测量外向性和神经质,并参与生活事件访谈和结构化临床访谈(SCID)以诊断精神疾病。
BA组的平均(标准差)年龄为45.6(12.3)岁,对照组为45.7(13.1)岁。所有患者均接受吸入性类固醇和常规β2激动剂治疗;9例BA患者但无对照组患者正在服用口服类固醇,12例BA患者但无对照组患者通过皮下输注或注射接受β2激动剂治疗。8例BA患者在GHQ上的得分超过11分,而对照组为5例(无显著性差异)。BA患者并发或既往有精神疾病的比例显著高于对照组(12/20)(5/20),20例BA患者中有7例有焦虑症终生史,而对照组为3/20。生活事件分析显示总数无总体差异,但BA患者与哮喘相关的生活事件显著更多。两组之间的人格特征无差异。
结果表明,“脆性”哮喘患者的精神疾病发病率高于病情较轻的哮喘患者,但其人格特征和总体生活事件经历相似。